Globeflex Capital L P Neurocrine Biosciences Inc Transaction History
Globeflex Capital L P
- $1.15 Billion
- Q4 2024
A detailed history of Globeflex Capital L P transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Globeflex Capital L P holds 23,404 shares of NBIX stock, worth $2.75 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
23,404
Previous 22,202
5.41%
Holding current value
$2.75 Million
Previous $2.56 Million
24.96%
% of portfolio
0.28%
Previous 0.25%
Shares
12 transactions
Others Institutions Holding NBIX
# of Institutions
655Shares Held
96.5MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.67 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.19 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$575 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$355 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$298 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.2B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...